ASPG and hypersensitivity: In 1984, Rachel et al. [45] reported that 75% of children with acute lymphoblastic leukemia developed hypersensitivity reactions and produced APAs following intravenous administration of PEGylated Erwinia asparaginase, leading to a rapid loss of enzymatic activity.